Irene Caesar, Ph.D. is a President and Founder of WAVE GENOME. She has founded WAVE GENOME in 2010 in Stamford, Connecticut, to lead the global QUANTUM LEAP in Laser Bioholography, Holonet (Holographic Biointernet), holographic drugs, Remote Bioengineering, and bioelectronics. WAVE GENOME is an American company, located now in Manchester, Connecticut, which is proud to be the leading competitor of major players in the field of bioelectronics, such as Elon Musk with his Neuralink, and Google with its R&D race for bioelectronic drugs. WAVE GENOME is ahead of Google for 8 years of actual sales and 50 years beyond R&D.
by Wavegenome
The device is the paradigmatic device for the personalized, addressed and preventive treatment. The technology is based upon recording client's Holographic Signal, for example, from his saliva or mucus, and, then, reversing or inverting this signal.
by Wavegenome
RA MINI-TESLA PSI-GENERATOR is the device enhancing the Wave Optics of chromosomes and protecting the user in the case of psychotronic and psychic attack.
by Wavegenome
SECOND-BIRTH TESLA PSI-GENERATOR has a more advanced, second generation chip encoded by laser on nano level with the most valuable bioholographic information on the global market: EMBRYONIC STEM CELL;
by Wavegenome
TESLA GLASSES X (Advanced Model) offers 11 modules similar to the modules of the BASIC TESLA GLASSES in addition to the low frequency electrical stimulation of the acupuncture points around eyes, and to the possibility to manually change the distance between the focus points in accordance with the distance between the pupils.
